To further approach the significance of subcellular ERβ localization in ovarian cancer, we examined co-expression of nuclear and cytoplasmic ERβ with various cancer-associated genes and steroid hormone receptors and tested to what extent receptor localization would affect survival of ovarian cancer patients. This evidence concerns the gene ESR2 and ovarian cancer.